$CERS News
Last published 1d ago
- 1d agoCERSCerus Corporation to Participate in the 17th Annual Craig-Hallum Alpha Select ConferenceBusiness WireCONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management will participate in and host one-on-one investor meetings at the 17th Annual Craig-Hallum Alpha Select Conference taking place in New York City on Tuesday, November 17. ABOUT CERUS Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to beco ...
- 1w agoCERSCERUS CORP - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 3w agoCERSCerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026Business WireCerus Corporation (NASDAQ:CERS) announced today that its third quarter 2026 financial results will be released on Monday, November 2, 2026, after the close of the stock market. The Company will host a conference call
- 4w agoCERSCerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual MeetingBusiness WireCerus Corporation (NASDAQ:CERS) announced today that it will host an industry workshop on the implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex, or IFC*, at the 2026
- 3mo agoCERSCerus Corp Q2 2026 Earnings Conference Call - CERUS CORPEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 3mo agoCERSCerus Corporation Announces Second Quarter 2026 Financial ResultsBusiness WireSecond Quarter 2026 Total Revenue of $63.3 million; Second Quarter 2026 Product Revenue of $57.4 million, +10% Y/Y Raising Lower End of 2026 Product Revenue Guidance: Range now $229 to $231 million; Raising 2026 IFC
- 3mo agoCERSCerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026Business WireCerus Corporation (NASDAQ:CERS) announced today that its second quarter 2026 financial results will be released on Thursday, July 30, 2026, after the close of the stock market. The Company will host a conference call
- 4mo agoCERSCerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT CongressBusiness WireCerus Corporation (NASDAQ:CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in
- 5mo agoCERSCerus Corporation Closes New Debt Facility of Up to $110 MillionBusiness WireRefinancing extends maturity and lowers cost of capital Enhances financial flexibility and positions Cerus to drive sustainable growth Anticipated annual cash interest expense savings of up to $3.5 million Cerus
- 5mo agoCERSCERUS CORPORATION ANNUAL MEETING OF STOCKHOLDERS - CERUS CORPEarnings Call TranscriptsGood morning. My name is Obi Greenman, President and Chief Executive Officer of Cirrus Corporation. I'm very happy to welcome you to the Cirrus Corp. 2026 Annual Stockholders Meeting. The meeting will now officially come
- 5mo agoCERSBradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann LucenaBusiness WireBradley L. Radoff, a significant shareholder of Cerus Corporation (NASDAQ:CERS) ("Cerus" or the "Company"), today announced his intention to withhold support for the Company's two director nominees at the upcoming 2026
- 6mo agoCERSCerus Corp Q1 2026 Earnings Conference Call - CERUS CORPEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the CEROS Corporation First Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there wil
- 6mo agoCERSCerus Corporation Announces First Quarter 2026 Financial ResultsBusiness WireFirst Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year Product Revenue Guidance Range to $227 million -
- 6mo agoCERSCerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood SystemBusiness WireCerus Corporation (NASDAQ:CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System. The agreement
- 7mo agoCERSCerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026Business WireCerus Corporation (NASDAQ:CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call
- 8mo agoCERSCerus Appoints Vivek Jayaraman as President and Chief Executive OfficerBusiness WireWilliam "Obi" Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026 Cerus Corporation (NASDAQ:CERS) today announced that Vivek Jayaraman, Cerus' chief operating officer, will be
- 8mo agoCERSCerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial ResultsBusiness Wire2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial Execution and Disciplined Operational
- 8mo agoCERSCerus Corporation to Participate in the TD Cowen 46th Annual Health Care ConferenceBusiness WireCerus Corporation (NASDAQ:CERS) announced today that members of the Company's management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30 a.m. EST. A live
- 8mo agoCERSCerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026Business WireCerus Corporation (NASDAQ:CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of the stock market. The Company will host a conference
- 11mo agoCERSCerus Corporation Announces Group Purchasing Agreement with Blood Centers of AmericaBusiness WireCerus Corporation (NASDAQ:CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member blood centers
- 1y agoCERSCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue GuidanceBusiness WireThird Quarter Total Revenue up 19% to $60.2 Million; Record Product Revenue of $52.7 Million, Up 15% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range to $202 Million - $204 Million Cerus
- 1y agoCERSCerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual MeetingBusiness WireCerus Corporation (NASDAQ:CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT Fibrinogen Complex, or
- 1y agoCERSCerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call
- 1y agoCERSThe German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet TransfusionsBusiness WireCerus Corporation (NASDAQ:CERS) announced today the publication of a new recommendation from the German National Blood Advisory Committee (Arbeitskreis Blut or AK Blut), which recommends proactive measures, including
- 1y agoCERSCerus Corporation to Participate in the Cantor Global Healthcare Conference 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that company management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 A.M. ET. A live
- 1y agoCERSCerus Corporation (CERS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCERSCerus Corporation Announces Second Quarter 2025 Financial ResultsBusiness WireSecond Quarter Total Revenue of $60.1 Million; Record Product Revenue of $52.4 Million, Up 16% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range to $200 Million - $203 Million Conference Call
- 1y agoCERSCerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a conference call
- 1y agoCERSCerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic InjuryBusiness WireAdditional Funding to Support Randomized Study Evaluating Earlier Access to INTERCEPT Fibrinogen Complex in Trauma Associated Hemorrhagic Shock Patients Cerus Corporation (NASDAQ:CERS) announced today that it has been
- 1y agoCERSCerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application UpdateBusiness WireCerus' Notified Body, TÜV-SÜD, has completed the review of the clinical module for the CE Mark submission for INTERCEPT Red Blood Cells (RBCs) Cerus Corporation (NASDAQ:CERS) announced today a European regulatory
- 1y agoCERSCerus Corporation Celebrates World Blood Donor Day 2025Business WireCerus Corporation (NASDAQ:CERS) is proud to announce its celebration of World Blood Donor Day 2025. In 2005, the World Health Assembly designated June 14th as World Blood Donor Day to recognize and thank blood donors
- 1y agoCERSCerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that members of the management team are scheduled to present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, Florida, on Wednesday, June 11,
- 1y agoCERSCerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in MilanBusiness WirePresentations and abstracts showcase the broad applicability and expected benefits of the INTERCEPT Blood System for platelets, plasma, IFC, and red blood cells Cerus Corporation (NASDAQ:CERS) today announced it will
- 1y agoCERSCerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination DeviceBusiness WireFrance and Switzerland approve INT200 for use with the INTERCEPT Blood System for Platelets and Plasma Cerus Corporation (NASDAQ:CERS) announced today two in-country regulatory approvals for INT200, one by the French
- 1y agoCERSCerus Corporation Announces First Quarter 2025 Financial ResultsBusiness WireFirst quarter 2025 Product Revenue of $43.2 Million, Up 13% Over Prior Year Reiterating Full-Year 2025 Product Revenue Guidance Range of $194 - $200 Million First Quarter 2025 Total Revenue of $48.9 Million Including
- 1y agoCERSCerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that its first quarter 2025 financial results will be released on Thursday, May 1, 2025, after the close of the stock market. The Company will host a conference call and
- 1y agoCERSCerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)Business WireRegulatory Approval Allows Company to Initiate Commercialization of the Illumination Device throughout the European Union Cerus Corporation (NASDAQ:CERS) announced today the CE mark approval of its next-generation
- 1y agoCERSCerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial ResultsBusiness WireFull-Year and Fourth Quarter 2024 Product Revenues Increased 15% and 9%, respectively, from Prior Year Periods Fourth straight quarter of positive operating cash flows Reiterating Full-Year 2025 Product Revenue
- 1y agoCERSCerus Corporation to Participate in the TD Cowen 45th Annual Health Care ConferenceBusiness WireCerus Corporation (NASDAQ:CERS) announced today that members of Cerus' management are scheduled to present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, at 11:10 a.m. EST. A live webcast of
- 1y agoCERSCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025Business WireCerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and full-year 2024 financial results will be released on Thursday, February 20, 2025, after the close of the stock market. The Company will host a
- 1y agoCERSCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business UpdateBusiness WirePreliminary Full-Year 2024 Product Revenues Total $180.3 million, 15% Over 2023 Results and Exceed Prior Product Revenue Guidance 2025 Product Revenues Expected to be Between $194-$200 million, Reflecting 8%-11%
- 1y agoCERSCerus Corporation to Participate in Upcoming Investor ConferencesBusiness WireCerus Corporation (NASDAQ:CERS) announced management participation in two upcoming investor conferences. Management plans to participate in the Stifel 2024 Healthcare Conference on Monday, November 18th at 4:10 PM ET,
- 2y agoCERSCerus Corporation (CERS) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoCERSCerus Corporation Announces Third Quarter 2024 Financial ResultsBusiness WireThird Quarter and First Nine-Month Product Revenue Increased 16% and 18%, respectively from Prior Year Periods Raising Full-Year 2024 Total Product Revenue Guidance to the Range of $177 million to $179 million and
- 2y agoCERSCerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024Business WireCerus Corporation (NASDAQ:CERS) announced today that its third quarter 2024 financial results will be released on Wednesday, October 30, 2024, after the close of the stock market. The Company will host a conference call
- 2y agoCERSCerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual MeetingBusiness WirePresentations Highlight the Unique Benefits of Real-world Utilization of INTERCEPT-treated Blood Products, Including INTERCEPT Fibrinogen Complex, and Recent Findings from the Phase 3 ReCePI Clinical Trial Cerus
- 2y agoCERSCerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and EuropeBusiness WireCompany to Host Conference Call and Webcast on Wednesday, October 16, 2024 at 5:00 p.m. EDT Cerus Corporation (NASDAQ:CERS) today announced updates on the INTERCEPT red blood cell (RBC) programs in the U.S. and in
- 2y agoCERSCerus Corporation (CERS) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoCERSCerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance RangeBusiness WireFirst Half of 2024 Product Revenue Increased 20% from Prior Year Period Increasing Full-Year 2024 Product Revenue Guidance Range from $172-175 Million to $175-178 Million Cerus Corporation (NASDAQ:CERS) today
- 2y agoCERSCerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024Business WireCerus Corporation (NASDAQ:CERS) announced today that its second quarter 2024 financial results will be released on Thursday, August 1, 2024, after the close of the stock market. The Company will host a conference call